Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 44%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc has demonstrated strong financial performance, with revenue growth of 76.5% year-over-year and a solid gross margin contributing to a positive outlook despite increased operating expenses. The rapid expansion of AI infrastructure has led to higher server shipments, propelling robust demand for the company's PCIe Gen 6 products, which now account for over 20% of revenue. With a strong revenue guidance of $249.0 million for the upcoming quarter and expectations for continued growth from AI server shipments, Astera's position as a leading semiconductor growth company is further solidified, despite concerns regarding valuation.

Bears say

Astera Labs Inc's revenue growth is heavily reliant on data center infrastructure spending, making it vulnerable to potential macroeconomic slowdowns that could impact capital investment. Additionally, while the company's non-GAAP operating expenses were reported at $70.7 million, this figure was below expectations, indicating potential inefficiencies or underperformance against anticipated operational goals. These factors contribute to a cautious outlook regarding the company’s fundamental performance and stock price trajectory.

ALAB has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 44% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 18 analysts, ALAB has a Buy consensus rating as of Jan 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $187.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $187.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.